MRKR Stock Price Increases Over 20% Pre-Market: Why It Happened

By Amit Chowdhry ● Mar 19, 2021
  • The stock price of TapImmune Inc. (NASDAQ: MRKR) increased by over 20% pre-market. This is why it happened.

The stock price of TapImmune Inc. (NASDAQ: MRKR) increased by over 20% pre-market.

Investors could be potentially responding to a report by GuruFocus that Peter L. Hoang, President and CEO of Marker Therapeutics, bought 142,857 shares of MRKR on March 16 at an average price of $1.75 a share. The total cost of the purchase was $250,000.

There are also a number of additional SEC filings showing that several other Marker Therapeutics have been acquiring shares as well.

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.